Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Swine Flu”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01206114
What this trial is testing

Evaluation of the Effectiveness of Vaccination With 2009 H1N1 Vaccines During Influenza Season 2010-11

Who this might be right for
Influenza Caused by the 2009 H1N1 Influenza Virus
Finnish Institute for Health and Welfare 2,351
Testing effectiveness (Phase 2)WithdrawnNCT01008956
What this trial is testing

Safety and Immune Response of One-Dose of Candidate H1N1 Influenza Vaccine GSK2340274A in Adults

Who this might be right for
Influenza
GlaxoSmithKline
Early research (Phase 1)Study completedNCT00724997
What this trial is testing

Randomized, Double-blind, Placebo-controlled, Phase I Dose-escalation Study of Single Dose GHB01L1 in Healthy Volunteers

Who this might be right for
Seasonal Human Influenza
AVIR Green Hills Biotechnology AG 48
Not applicableStudy completedNCT03641690
What this trial is testing

Serum and Bronchoalveolar Inflammatory Parameters in Patients With Severe Adult Respiratory Distress Syndrome

Who this might be right for
H1N1 Influenza
Centre Hospitalier Universitaire, Amiens 97
Testing effectiveness (Phase 2)Study completedNCT00975572
What this trial is testing

Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Population Aged 3 Years and Older

Who this might be right for
Virus DiseasesRespiratory Tract DiseasesRespiratory Tract Infections+2 more
Jiangsu Province Centers for Disease Control and Prevention 2,200
Large-scale testing (Phase 3)Study completedNCT00970177
What this trial is testing

Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of Age

Who this might be right for
Pandemic Influenza
Novartis Vaccines 812
Large-scale testing (Phase 3)Study completedNCT01201902
What this trial is testing

Evaluate the Safety and Immunogenicity of an Inactivated Split-virion Influenza A(H1N1) Vaccine

Who this might be right for
Influenza Infection
Green Cross Corporation 592
Large-scale testing (Phase 3)Study completedNCT00989287
What this trial is testing

Immunogenicity and Safety Study of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults

Who this might be right for
Influenza
GlaxoSmithKline 131
Testing effectiveness (Phase 2)Study completedNCT01052480
What this trial is testing

Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza

Who this might be right for
Influenza AInfluenza B
National Institute of Allergy and Infectious Diseases (NIAID) 98
Post-approval studies (Phase 4)Study completedNCT01111162
What this trial is testing

H1N1 Influenza Vaccine Immunogenicity in HIV-1 Infected Patients

Who this might be right for
HIV Infections
University of Pennsylvania 120
Post-approval studies (Phase 4)Study completedNCT01004653
What this trial is testing

A Clinical Trial of Split-virion Influenza A/H1N1 Vaccines

Who this might be right for
Influenza
Sinovac Biotech Co., Ltd 100
Testing effectiveness (Phase 2)Study completedNCT03180801
What this trial is testing

Efficacy of FLU-v in an H1N1 Influenza Human Challenge Model

Who this might be right for
Influenza
PepTcell Limited 153
Large-scale testing (Phase 3)Study completedNCT00996138
What this trial is testing

Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Adult Subjects

Who this might be right for
Influenza
Novartis Vaccines 200
Not applicableStudy completedNCT05080933
What this trial is testing

ECMO for COVID-19 vs Influenza A H1N1 Associated ARDS

Who this might be right for
ARDSCOVID-19H1N1 Influenza
University of Turin, Italy 308
Post-approval studies (Phase 4)WithdrawnNCT01097941
What this trial is testing

Effect of Age and Prior Immunity on Response to H1N1 Vaccines in Children

Who this might be right for
2009 H1N1 Influenza
University of Rochester
Post-approval studies (Phase 4)UnknownNCT00936013
What this trial is testing

Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1)Pneumonia: Multi-centre, Prospective, Randomized Controlled Study

Who this might be right for
Influenza
Capital Medical University 400
Testing effectiveness (Phase 2)Ended earlyNCT01798602
What this trial is testing

Collaborative H1N1 Adjuvant Treatment (CHAT) Pilot Trial

Who this might be right for
H1N1 Influenza
Canadian Critical Care Trials Group 8
Large-scale testing (Phase 3)Ended earlyNCT01014364
What this trial is testing

Low Doses Corticosteroids as Adjuvant Therapy for the Treatment of Severe H1N1 Flu

Who this might be right for
Pneumonia, ViralInfluenza in Humans
University of Versailles 40
Not applicableStudy completedNCT00996853
What this trial is testing

Post-Authorization Safety Study of GSK Biologicals' Pandemic Influenza Vaccine (H1N1) in the United Kingdom

Who this might be right for
Influenza
GlaxoSmithKline 9,206
Testing effectiveness (Phase 2)Study completedNCT00963157
What this trial is testing

Sanofi H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly Populations

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 789
Next Page